Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02632305
Title A Study to See the Effects That a New Combination of the Three Drugs, Nab-paclitaxel, Gemcitabine, and Cisplatin Has on Biliary Tract Cancer (AX-CSARC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AHS Cancer Control Alberta
Indications

cholangiocarcinoma

ampulla of Vater carcinoma

intrahepatic cholangiocarcinoma

gallbladder cancer

Therapies

Cisplatin + Gemcitabine + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.